Showing results (181-190 of 319) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2020
Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III TrialRichard T Penson, Ricardo Villalobos Valencia, David Cibula, et al.
Diagnostics (Basel, Switzerland)|January 11, 2024
Sonographic, Demographic, and Clinical Characteristics of Pre- and Postmenopausal Women with Endometrial Cancer; Results from a Post Hoc Analysis of the IETA4 (International Endometrial Tumor Analysis) Multicenter CohortRasmus W Green, Daniela Fischerová, Antonia C Testa, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 7, 2023
AGO-OVAR 28/ENGOT-ov57. Niraparib alone versus niraparib in combination with bevacizumab in patients with carboplatin-taxane-based chemotherapy in advanced ovarian cancer: a multicenter randomized phase III trialFlorian Heitz, Christian Marth, Stéphanie Henry, et al.
Annals of Surgical Oncology|June 14, 2017
Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter StudyLucas Minig, Florian Heitz, David Cibula, et al.
International Journal of Cancer|January 29, 2026
The cervico-vaginal DNA methylation WID-qEC test: An epigenetic marker associated with ovarian cancer in the absence of endometrial and cervical cancerElisa Redl, Chiara Herzog, Charlotte Vavourakis, et al.
Reproductive Health|May 7, 2026
Tailored-prom: tailored therapeutic regime in patients with preterm premature rupture of membranes to prolong pregnancy, improve maternal and neonatal outcomes, and reduce antibiotic burden: a randomized controlled trial protocolKarolina Mikova, Anna Jouzova, Zdenek Lastuvka, et al.
Breast Cancer Research : BCR|June 29, 2023
Effectiveness of palbociclib with aromatase inhibitors for the treatment of advanced breast cancer in an exposure retrospective cohort study: implications for clinical practiceFilipa Alves da Costa, Fábio Cardoso Borges, Adriana Ramos, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2011
Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITOPhilipp Harter, Jalid Sehouli, Alexander Reuss, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 10, 2025
A randomized, phase III study of sacituzumab govitecan versus treatment of the physician's choice in patients with endometrial cancer after platinum-based chemotherapy and immunotherapy: the ASCENT-GYN-01 study (GOG-3104/ENGOT-en26/APGOT-EN2)Ramez N Eskander, Bradley Corr, David Cibula, et al.
Gynecologic Oncology|September 5, 2012
Bilateral ultrastaging of sentinel lymph node in cervical cancer: Lowering the false-negative rate and improving the detection of micrometastasisDavid Cibula, Nadeem R Abu-Rustum, Ladislav Dusek, et al.
Pageof 32